| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2006 | WO2006089054A1 New isothiazoloquinolones and related compounds as anti-infective agents |
| 08/24/2006 | WO2006089053A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 08/24/2006 | WO2006088988A1 Crystalline form of an indazole-carboxamide compound |
| 08/24/2006 | WO2006088958A2 Encapsulated (chelate or ligand) dendritic polymers |
| 08/24/2006 | WO2006088954A1 Dihydroindolyl methanones as alpha 1a/1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 08/24/2006 | WO2006088949A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | WO2006088944A1 Sphingosine 1- phos phate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups |
| 08/24/2006 | WO2006088923A2 A food containing a probiotic and an isolated beta-glucan and methods of use thereof |
| 08/24/2006 | WO2006088921A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088919A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088903A2 Pyrazole compounds |
| 08/24/2006 | WO2006088875A2 Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels |
| 08/24/2006 | WO2006088840A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088837A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088836A2 Piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088824A2 Compounds useful for treating hiv |
| 08/24/2006 | WO2006088813A1 Substituted pyrazoles as modulators of chemokine receptors |
| 08/24/2006 | WO2006088798A2 Modulation of hypothalamic atp-sensitive potassium channels |
| 08/24/2006 | WO2006088786A2 Compounds and uses thereof |
| 08/24/2006 | WO2006088784A1 Use of estrogen receptor-b selective agonists for radiation-or chemotherapy-induced mucosistis and radiation cystitis |
| 08/24/2006 | WO2006088767A2 C10 cyclopropyl ester substituted taxane compositions |
| 08/24/2006 | WO2006088765A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 08/24/2006 | WO2006088753A2 Method for decreasing cartilage damage in dogs |
| 08/24/2006 | WO2006088748A2 Method for treating obesity |
| 08/24/2006 | WO2006088720A2 9-substituted tetracyclines |
| 08/24/2006 | WO2006088705A1 Terphenyl guanidines as [beta symbol] -secretase inhibitors |
| 08/24/2006 | WO2006088694A1 SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS |
| 08/24/2006 | WO2006088676A2 Method of modulating drug release from a coated substrate |
| 08/24/2006 | WO2006088648A1 Compositions and methods for treating dyslipidemia |
| 08/24/2006 | WO2006088541A2 Quinoline derivatives and uses thereof |
| 08/24/2006 | WO2006088491A2 Methods and compositions related to the modulation of intercellular junctions |
| 08/24/2006 | WO2006088483A2 Compositions and methods for inhibiting the synthesis or expression of mmp-1 |
| 08/24/2006 | WO2006088476A2 Carboranylporphyrins and uses thereof |
| 08/24/2006 | WO2006088473A2 Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents |
| 08/24/2006 | WO2006088315A1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 08/24/2006 | WO2006088310A1 A pharmaceutical composition comprising retinoid for prevention and treatment of vitiligo |
| 08/24/2006 | WO2006088246A1 Agent for controlling function of gpr34 receptor |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088193A1 Anti-tumor agent |
| 08/24/2006 | WO2006088191A1 Eudistomin derivative |
| 08/24/2006 | WO2006088188A1 Oil-and-fat composition |
| 08/24/2006 | WO2006088173A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity |
| 08/24/2006 | WO2006088134A1 Method of relieving or avoiding side effect of steroid compound |
| 08/24/2006 | WO2006088129A1 Salt of proline derivative, solvate thereof, and production method thereof |
| 08/24/2006 | WO2006088088A1 Pain remedy containing rock inhibitor |
| 08/24/2006 | WO2006088080A1 CYCLOHEPTA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006088017A1 Sugar chain containing 4-position halogenated galactose and application thereof |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006088010A1 Antimicrobial peptide and use thereof |
| 08/24/2006 | WO2006087997A1 1-SUBSTITUTED-7-(β-D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
| 08/24/2006 | WO2006087935A1 Pharmaceutical composition containing phenoxazinium compound as active ingredient |
| 08/24/2006 | WO2006087919A1 Finely divided composition containing poorly water soluble substance |
| 08/24/2006 | WO2006087759A2 Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field |
| 08/24/2006 | WO2006087752A2 Cationic lipids for the transfection of nucleic acids |
| 08/24/2006 | WO2006087722A1 Bisphosphonates for treating endometriosis |
| 08/24/2006 | WO2006087718A1 Extension of lifespan with drugs |
| 08/24/2006 | WO2006087639A1 Composition comprising ocaperidone |
| 08/24/2006 | WO2006087629A2 Rapidly disintegrating composition of olanzapine |
| 08/24/2006 | WO2006087577A2 Inhibition or treatment of dyskinesia |
| 08/24/2006 | WO2006087548A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 08/24/2006 | WO2006087543A1 Antibacterial piperidine derivatives |
| 08/24/2006 | WO2006087538A1 Chemical compounds |
| 08/24/2006 | WO2006087536A1 Compounds |
| 08/24/2006 | WO2006087530A1 Chemical compounds |
| 08/24/2006 | WO2006087481A1 Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
| 08/24/2006 | WO2006087480A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 08/24/2006 | WO2006087420A2 A method for treating heart failure |
| 08/24/2006 | WO2006087419A2 A method for administering levosimendan |
| 08/24/2006 | WO2006087404A1 Stabilised amorphous calcium atorvastatin and production method thereof |
| 08/24/2006 | WO2006087395A1 Multimicroparticulate oral pharmaceutical form with modified release of angiotensin ii receptor antagonists |
| 08/24/2006 | WO2006087394A1 Oral pharmaceutical for of losartan |
| 08/24/2006 | WO2006087387A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
| 08/24/2006 | WO2006087371A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 08/24/2006 | WO2006087369A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using them |
| 08/24/2006 | WO2006087355A1 1h-imidiazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | WO2006087316A1 Pharmaceutical compositions comprising anticholinergics and etiprednol |
| 08/24/2006 | WO2006087315A1 Novel, long-acting betamimetics for treating respiratory diseases |
| 08/24/2006 | WO2006087312A1 Tablets comprising a biologically active substance and an excipient containing calcium carbonate |
| 08/24/2006 | WO2006087309A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 08/24/2006 | WO2006087308A1 METHYLPHENYLCARBAMIC ACID 5-(4-ISOBUTYL-2,6,-DIOXOPIPERAZIN-l-YL) PYRIDINYL-2-YL ESTER ANS SALTS AS HORMONE SENSITIVE LIPASE INHIBITORS |
| 08/24/2006 | WO2006087306A2 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors |
| 08/24/2006 | WO2006087305A1 Novel diazabicyclic aryl derivatives and their medical use |
| 08/24/2006 | WO2006087232A1 L-aspartic acid for the treatment of problems in connection with the fat or glucose metabolism |
| 08/24/2006 | WO2006087230A1 Use of cdk ii inhibitors for fertility control |
| 08/24/2006 | WO2006087229A1 Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders |
| 08/24/2006 | WO2006087173A1 Contraceptive pharmaceutical preparation |
| 08/24/2006 | WO2006087169A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 08/24/2006 | WO2006087164A1 Compositions containing polysaccharides |
| 08/24/2006 | WO2006087147A2 Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of fibromyalgia |
| 08/24/2006 | WO2006087145A1 Device and method for identifying mycotoxins |
| 08/24/2006 | WO2006087135A1 Tetrazine derivatives having an antimycotic effect, and use thereof |
| 08/24/2006 | WO2006087117A1 Therapeutic combinations of manidi pine and a statin |
| 08/24/2006 | WO2006087116A1 Oral dosage form comprising rosiglitazone |
| 08/24/2006 | WO2006087077A2 Hsp90-inhibiting triazole derivatives |
| 08/24/2006 | WO2006086986A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | WO2006086985A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | WO2006086978A2 Use of deuterated n-[2-(5-methoxy-1h-indol-3-yl)-ethyl]acetamides and the pharmaceutically acceptable salts thereof, and medicaments containing said compounds |
| 08/24/2006 | WO2006086923A1 4-hydroxy pentanamides, the preparation and use thereof |